跳至主要内容
临床试验/NCT04123340
NCT04123340已完成2 期

Intraprocedural Assessment of Ablation Margins Using Computed Tomography Co-registration in Primary Liver Tumor Treatment With Percutaneous Ablation

Leiden University Medical Center2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2019年8月26日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
20
试验地点
2
主要终点
Feasibility of the use of co-registration software (>80%)

研究概览

简要总结

A pre- and postablation scan will be made intraprocedurally to investigate the feasibility of intraprocedural ablation verification assessment using coregistration software

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

盲法说明

post-procedural an assessment will be done of the ablation completeness using registration software. The actual ablation verification will be done qualitatively by the treating physician.

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 yrs or above
  • HCC very early (0) or early stage (A) according to the BCLC staging system
  • Either de novo or recurrent HCC (prior locoregional therapy is allowed in the study)
  • Candidate for percutaneous thermal ablation as discussed in a multidisciplinary tumor board. Ablation as 'bridge-to-transplant' is allowed in the study

排除标准

  • Estimated GFR <30 ml/min
  • Morbid obesitas or any pulmonary condition that is a contraindication to prolonged apnea and high jet-ventilation
  • Child Pugh C
  • Portal vein tumor invasion
  • Extrahepatic metastasis
  • Uncorrectable coagulopathy
  • Any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule
  • Inability or unwillingness to give informed consent

结局指标

主要结局

Feasibility of the use of co-registration software (>80%)

时间窗: 1 year

The proportion of patients in whom reliable co-registration of pre- and post-ablation CT images is feasible

次要结局

  • The time that is required for CT-CT co-registration(1 year)
  • Inter and intra-observer variability(1 year)
  • Quantitatively assessed ablation margin(1 year)

研究者

发起方
Leiden University Medical Center
申办方类型
Other
责任方
Principal Investigator
主要研究者

MCBurgmans

Principal Investigator

Leiden University Medical Center

研究点 (2)

Loading locations...

相似试验